Tuberous Sclerosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex
Conditions:   Facial Angiofibroma;   Tuberous Sclerosis Interventions:   Drug: rapamycin;   Drug: placebo Sponsor:   Dermatology Specialties Limited Partnership Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2019 Category: Research Source Type: clinical trials